The Vanguard Group 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:04 pm Sale |
2023-12-29 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
The Vanguard Group | 638,124 4.910% |
-125,683 (-16.45%) |
Filing |
| 2023-02-09 11:16 am Purchase |
2022-12-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
The Vanguard Group | 763,807 5.870% |
3,339 (+0.44%) |
Filing |
| 2022-02-09 3:43 pm Sale |
2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
The Vanguard Group | 760,468 5.890% |
-4,467 (-0.58%) |
Filing |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
The Vanguard Group | 764,935 5.870% |
4,565 (+0.60%) |
Filing |